Rea Amanda, Salenger Rawn, Grant Michael C, Yeh Jennifer, Damas Barbara, Crisalfi Cheryl, Arora Rakesh, Gregory Alexander J, Morton-Bailey Vicki, Engelman Daniel T
Division of Cardiac Surgery, University of Maryland St Joseph Medical Center, Towson, Md.
Department of Surgery, University of Maryland School of Medicine, Baltimore, Md.
JTCVS Open. 2024 Jun 25;22:1-13. doi: 10.1016/j.xjon.2024.06.009. eCollection 2024 Dec.
The management of preoperative medications is an essential component of perioperative care for the cardiac surgical patient. This turnkey order set is part of a series created by the Enhanced Recovery After Surgery Cardiac Society, first presented at the Annual Meeting of The American Association for Thoracic Surgery in 2023. Numerous guidelines and expert consensus documents have been published to provide guidance in preoperative medication management. Our objective is to integrate these documents into an evidence-based order set that will facilitate standardized implementation of best practices for preoperative medication management for nonemergent adult cardiac surgery.
Subject matter experts were consulted to translate existing guidelines and peer reviewed literature into a sample turnkey order set for the preoperative management of patients' medications. Orders derived from consistent Class I, IIA, or equivalent recommendations across referenced guidelines and consensus manuscripts appear in the order set in type. Selected orders that were inconsistently Class I or IIA, Class IIB, or supported by published evidence, were also included in type.
Holding antiplatelet and anticoagulant medications before nonemergent cardiac surgical procedures may reduce the risk of bleeding. Sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 agonists should also be discontinued to prevent acidosis and aspiration, respectively. Specific guidance for frequently used medications are complied within the manuscript, less frequently used medications are listed seperately.
Despite strong recommendations from major guidelines and consensus manuscripts, variation exists in preoperative medication orders, with limited availability of succinct implementation tools. This turnkey order set may facilitate standardized comprehensive preoperative medication management before nonemergent cardiac surgery.
术前用药管理是心脏外科手术患者围手术期护理的重要组成部分。这个一站式订单集是由心脏外科手术后加速康复协会创建的系列的一部分,于2023年在美国胸外科协会年会上首次展示。已经发布了许多指南和专家共识文件,为术前用药管理提供指导。我们的目标是将这些文件整合到一个循证订单集中,以促进非急诊成人心脏手术术前用药管理最佳实践的标准化实施。
咨询主题专家,将现有指南和同行评审文献转化为患者术前用药管理的样本一站式订单集。源自参考指南和共识手稿中一致的I类、IIA类或同等推荐的医嘱以 类型出现在订单集中。不一致的I类或IIA类、IIB类或有已发表证据支持的选定医嘱也以 类型纳入。
在非急诊心脏手术前停用抗血小板和抗凝药物可能会降低出血风险。钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽1激动剂也应分别停用,以预防酸中毒和误吸。手稿中包含了常用药物的具体指导,不常用药物单独列出。
尽管主要指南和共识手稿给出了强烈建议,但术前用药医嘱仍存在差异,简洁的实施工具也有限。这个一站式订单集可能有助于非急诊心脏手术前标准化的全面术前用药管理。